Spread of Paravertebral Injections in the Lumbar Plexus Area

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03335462
• Date of registration: 31/10/2017
• Prospective Registration: Yes
• Primary sponsor: Makassed General Hospital
• Public title: Spread of Paravertebral Injections in the Lumbar Plexus Area
• Scientific title: The Spread of Paravertebral Injections in the Lumbar Plexus Area and Associated Risk Factors to Adjacent Organs: a CT Scan Based Report
• Date of first enrolment: November 2, 2017
• Target sample size: 30
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03335462
• Study type: Interventional
• Study design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
• Phase: N/A

Countries of recruitment

Lebanon

Contacts

• Name: Zoher Naja, MD
• Affiliation: Makassed General Hospital

Key inclusion & exclusion criteria

Inclusion Criteria:

- Older than 18 years

- Scheduled for hernia repair

Exclusion Criteria:

Patients

- with coagulation disorders,

- with infection at the injection site,

- with allergy to contrast

- receiving opioids



Age minimum: 18 Years
Age maximum: N/A
Gender: Male

Health Condition(s) or Problem(s) studied

Lumbar Plexus Block

Intervention(s)

Other: CT scan

Other: Paravertebral injections

Primary Outcome(s)

Injection spread [Time Frame: 5 minutes after the procedure]

Secondary Outcome(s)

Distance between injections and kidney [Time Frame: 5 minutes after the procedure]

Secondary ID(s)

12112008

Source(s) of Monetary Support

Please refer to primary and secondary sponsors